EPS (Diluted) for AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's current diluted EPS (TTM) is $2.37. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
ABBV
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$2.37
YoY change
-0.8%
5Y CAGR
-2.7%
Peak year (2022)
$6.63
Latest annual
$2.37
EPS (Diluted) history chart for AbbVie (ABBV) from 2009 to 2025
EPS (Diluted) history table for AbbVie (ABBV) from 2009 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $2.37 | -0.8% | ||
| 2024 | $2.39 | -12.1% | ||
| 2023 | $2.72 | -59.0% | ||
| 2022 | $6.63 | +2.8% | ||
| 2021 | $6.45 | +137.1% | ||
| 2020 | $2.72 | -48.5% | ||
| 2019 | $5.28 | +43.5% | ||
| 2018 | $3.68 | +11.5% | ||
| 2017 | $3.30 | -9.1% | ||
| 2016 | $3.63 | +16.0% | ||
| 2015 | $3.13 | +184.5% | ||
| 2014 | $1.10 | -57.0% | ||
| 2013 | $2.56 | -23.6% | ||
| 2012 | $3.35 | +58.8% | ||
| 2011 | $2.11 | -17.9% | ||
| 2010 | $2.57 | -9.8% | ||
| 2009 | $2.85 | — |
EPS (Diluted) values are taken from AbbVie's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, AbbVie (ABBV) diluted EPS totalled $2.37 – edged down 0.8% year-over-year.
AbbVie diluted EPS compound annual growth for the 2020–2025 (5 years) window is -2.7%, with a net decline across the window.
Between 2022 and 2025, AbbVie diluted EPS plunged 64.3%, falling from $6.63 to $2.37.
$6.63 stands as the all-time-high annual diluted EPS, posted in 2022, against a low of $1.10 during 2014.
Among 8 Healthcare peers, AbbVie (ABBV) ranks 9th; the peer median for diluted EPS is $13.73.
AbbVie EPS (Diluted) by Year
AbbVie EPS (Diluted) 2025: $2.37
AbbVie diluted EPS in 2025 was $2.37, edged down 0.8% below 2024.
AbbVie EPS (Diluted) 2024: $2.39
AbbVie diluted EPS in 2024 was $2.39, declined 12.1% below 2023.
AbbVie EPS (Diluted) 2023: $2.72
AbbVie diluted EPS in 2023 was $2.72, plunged 59.0% below 2022.
AbbVie EPS (Diluted) 2022: $6.63
AbbVie diluted EPS in 2022 was $6.63, edged up 2.8% from 2021. This figure represents the highest annual value in the available history.
AbbVie EPS (Diluted) 2021: $6.45
AbbVie diluted EPS in 2021 was $6.45.
See more financial history for AbbVie (ABBV).
Sector peers — EPS (Diluted)
Companies in the same sector as AbbVie, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $17.74 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
Frequently asked questions
What is AbbVie's diluted EPS?
- Latest reported diluted EPS for AbbVie (ABBV) is $2.37 (period ending December 31, 2025).
How has AbbVie diluted EPS changed year-over-year?
- AbbVie (ABBV) diluted EPS changed -0.8% year-over-year on the latest annual filing.
What is the long-term growth rate of AbbVie diluted EPS?
- AbbVie (ABBV) diluted EPS compound annual growth rate is -2.7% over the most recent 5 years available.
When did AbbVie diluted EPS hit its highest annual value?
- AbbVie diluted EPS reached its highest annual value of $6.63 in 2022.
What was AbbVie diluted EPS in 2024?
- AbbVie (ABBV) diluted EPS in 2024 was $2.39.
What was AbbVie diluted EPS in 2025?
- AbbVie (ABBV) diluted EPS in 2025 was $2.37.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABBV Overview
Company profile, financial tools, and key metrics
ABBV Revenue Counter
Earns $1,939 every second. See per minute, hour, and day.
ABBV Earnings Counter
Earns $134.01 per second net profit. See per minute, hour, and day.
ABBV Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
ABBV What If Invested
What if you had invested $1,000? See historical returns from any date.
ABBV How It Makes Money
Discover visual breakdown of $61.16B in revenue — where it comes from and where it goes.
ABBV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABBV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABBV Daily Price Character
Steady · 53.5% historical win rate (green days). Streaks & record days.
ABBV Buybacks
0.24% TTM buyback yield. Shareholder yield & SBC comparison.
ABBV Dividend Profile
Yield: 3.31%. Safety: 6/8. See full history.
ABBV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABBV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.